Cargando…
Pathway with single‐dose long‐acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections
OBJECTIVES: Emergency department (ED) patients with serious skin and soft tissue infections (SSTIs) are often hospitalized to receive intravenous (IV) antibiotics. Appropriate patients may avoid admission following a single‐dose, long‐acting IV antibiotic. METHODS: We conducted a preintervention ver...
Autores principales: | Talan, David A., Mower, William R., Lovecchio, Frank A., Rothman, Richard E., Steele, Mark T., Keyloun, Katelyn, Gillard, Patrick, Copp, Ronald, Moran, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597095/ https://www.ncbi.nlm.nih.gov/pubmed/33780567 http://dx.doi.org/10.1111/acem.14258 |
Ejemplares similares
-
456. Dalbavancin, a Long-Acting Lipoglycopeptide Antimicrobial Agent, Reduces Length of Stay and Improves Patient Work Productivity in a Hospital Critical Pathway for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)—the ENHANCE ABSSSI Trial
por: McCarthy, Matthew W, et al.
Publicado: (2019) -
1332 A Randomized, Double-Blind, Placebo-Controlled Trial of Trimethoprim-sulfamethoxazole vs. Placebo for Patients with an Incised and Drained Cutaneous Abscess
por: Talan, David, et al.
Publicado: (2014) -
Factors Associated with Decision to Hospitalize Emergency Department Patients with Skin and Soft Tissue Infection
por: Talan, David A., et al.
Publicado: (2015) -
Current Use of Intravenous (IV) Long Acting Antibiotic (LAA) Therapy in the Aetna Health Plan among Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
por: Mehta, Rajesh, et al.
Publicado: (2017) -
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
por: McCarthy, Matthew W., et al.
Publicado: (2019)